Gilead Sciences, Inc. (GILD)
147.09
-0.55
(-0.37%)
USD |
NASDAQ |
Feb 25, 16:00
147.09
0.00 (0.00%)
After-Hours: 16:25
Gilead Sciences Market Cap : 182.49B for Feb. 25, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amgen, Inc. | 207.17B |
| Johnson & Johnson | 590.86B |
| Eli Lilly & Co. | 970.64B |
| Regeneron Pharmaceuticals, Inc. | 82.90B |
| Moderna, Inc. | 20.08B |
Market Cap Related Metrics
| PE Ratio | 21.69 |
| PS Ratio | 6.276 |
| PEG Ratio | 0.0125 |
| Price to Book Value | 8.068 |
| Price to Free Cash Flow | 18.43 |
| Price | 147.09 |
| Earnings Yield | 4.61% |
| PEGY Ratio | 0.0125 |
| Operating PE Ratio | 15.66 |